NCT03776019

Brief Summary

It is anticipated that Audio-Visual-Perception-Enhancement (AVWF®) method leads to pain reduction and a decrease of inflammatory markers in chronic pain patients. Also an improvement of quality of life, self-perceived disability and depression in chronic pain patients is expected.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 10, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 14, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

February 15, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2019

Completed
Last Updated

September 9, 2020

Status Verified

September 1, 2020

Enrollment Period

10 months

First QC Date

December 10, 2018

Last Update Submit

September 8, 2020

Conditions

Keywords

PainStressAVWFAudio-Visual-Perception-Enhancement

Outcome Measures

Primary Outcomes (1)

  • Change in Numeric Rating Scale of Pain Severity

    Validated 11 pt scale 0-10, to evaluate a patient's current severity of pain. A rating of 0 indicates no pain while 10 indicates the worst pain imaginable. A score of 4 or above is considered a clinically significant pain Level.

    Change from baseline Numeric Rating Scale of Pain Severity after 10 interventions, 4 weeks after the last intervention, and 3 month after the last intervention

Secondary Outcomes (6)

  • Health related quality of life

    Change from baseline health related quality of life after 10 interventions, 4 weeks after the last intervention, and 3 month after the last intervention

  • Hospital Anxiety and Depression Scale

    Change from baseline Hospital Anxiety and Depression Scale after 10 interventions, 4 weeks after the last intervention, and 3 month after the last intervention

  • Pittsburgh Sleep Quality Index

    Change from baseline Pittsburgh Sleep Quality Index after 10 interventions, 4 weeks after the last intervention, and 3 month after the last intervention

  • Depression Anxiety Stress Scales

    Change from baseline Depression Anxiety Stress Scales after 10 interventions, 4 weeks after the last intervention, and 3 month after the last intervention

  • Pain Disability Index

    Change from baseline Pain Disability Index after 10 interventions, 4 weeks after the last intervention, and 3 month after the last intervention

  • +1 more secondary outcomes

Study Arms (2)

Modulated

EXPERIMENTAL

modulated music

Device: AVWF device

Typical

SHAM COMPARATOR

typical music

Device: AVWF device

Interventions

The AVWF method utilizes sound modulated music, which is thought to regulate the vagus nerve.

ModulatedTypical

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • chronic low back pain with a numeric rating scale of pain \>= 4 for \> 6 month
  • patients \>18 years

You may not qualify if:

  • psychosis
  • drug addiction
  • pension process
  • pregnant women
  • epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Klinikum Klagenfurt am Wörthersee

Klagenfurt, 9020, Austria

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Rudolf Likar

    Head of department

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prim.Univ.Prof.Dr.

Study Record Dates

First Submitted

December 10, 2018

First Posted

December 14, 2018

Study Start

February 15, 2019

Primary Completion

December 20, 2019

Study Completion

December 20, 2019

Last Updated

September 9, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations